Feasibility of hypnotherapy for young cancer patients
HYPNotherapy for Improving Distress and Sleep in Adolescents and Young Adults With Cancer; a Feasibility Study (HYPNAYA Feasibility Study)
This study is testing if hypnotherapy can help young cancer patients aged 18-39 feel less stressed, sleep better, and improve their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 39 Years |
| Sex | All |
| Sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 2 sites (Amsterdam, Noord-Holland and 1 other locations) |
| Trial ID | NCT06021093 on ClinicalTrials.gov |
What this trial studies
This study investigates the feasibility of using hypnotherapy as a supportive treatment for adolescents and young adults (AYAs) diagnosed with cancer. Participants aged 18-39 will receive two individual hypnotherapy sessions along with home-based exercises and standardized hypnosis recordings. The study will assess the impact of hypnotherapy on stress, sleep, and health-related quality of life through questionnaires administered at baseline, 8 weeks, and 12 weeks after the first session. The research is conducted at the Amsterdam UMC, focusing on AYAs undergoing systemic treatment or follow-up care.
Who should consider this trial
Good fit: Ideal candidates are adolescents and young adults aged 18-39 currently undergoing cancer treatment or follow-up care.
Not a fit: Patients actively treated by a psychiatrist or those who have previously received hypnotherapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce distress and improve the quality of life for young cancer patients.
How similar studies have performed: While hypnotherapy has been explored in various contexts, this specific approach for AYAs with cancer is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria * Consecutive AYA patients undergoing systemic treatment or follow-up up to 6 months after finishing medical treatment at the Amsterdam University Medical Centers in Amsterdam, will be invited to participate. * The Dutch definition of AYA is patients aged 18-39 years at cancer diagnosis. * All patients need to be fluent in Dutch * Able to understand the informed consent form * Willing to provide written informed consent. Exclusion criteria * Patients that are actively treated by a psychiatrist will not be able to participate in this study to prevent interference with ongoing psychiatric treatment. * Patients that are mentally incompetent (based on the opinion of the treating physician) will be excluded. * Patients that previously received hypnotherapy will also be excluded.
Where this trial is running
Amsterdam, Noord-Holland and 1 other locations
- Amsterdam UMC, location VUMC — Amsterdam, Noord-Holland, Netherlands (Recruiting)
- Amsterdam UMC, location AMC — Amsterdam, Noord-Holland, Netherlands (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.